The Clinical Trial Supplies market is driven by advanced technologies like blockchain and IoT in supply chain management. The market is projected to increase from US$2.70 Bn in 2024 to US$4.79 Bn by 2033, achieving a CAGR of 6.58% throughout the...
Lipella Pharmaceuticals Inc has reported the conclusion of dosing for the initial group in its multi-center phase 2a clinical trial for LP-310, a liposomal-tacrolimus oral rinse intended for treating oral lichen planus (OLP). In the initial group...
Marksans Pharma Limited has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg. These tablets are intended for over-the-counter (OTC) use to tre...
In 2023, international pharmaceutical firms supplied clinical trial medications to local patients valued at approximately 320.8 billion. The overall quantity of clinical trials carried out that year was 1,723, reflecting a 7.7 percent rise...
SystImmune, Inc (SystImmune), a biotechnology company in the clinical stage, declared that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for BL-M17D1, an antibody-drug conjugate (ADC)...
CytoDyn Inc., a biotech firm working on leronlimab, a CCR5 inhibitor with possible therapeutic uses, revealed that it has obtained approval from the US FDA to begin its phase II cancer trial. The research will assess how effective leronlimab is...
.JPG)
HuidaGene Therapeutics (HuidaGene), a worldwide biotech company focused on genome medicines in clinical trials, revealed that the US FDA has approved its HG202 investigational new drug (IND) application for neovascular age-related macular...
A graphene-based brain chip is entering its first clinical trial at Salford Royal Hospital, aiming to revolutionize brain tumor surgeries, according to The Guardian. The device, roughly postage-stamp sized, works by detecting cancer cells through ...
Medicines for Malaria Venture (MMV) and Quotient Sciences have begun the first clinical trial for a long-acting injectable (LAI) preventive compound for malaria. The trial, conducted in healthy volunteers in Nottingham, UK, marks a significant...
Tyra Biosciences, Inc., a biotechnology company in the clinical development stage, revealed that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for TYRA-300, enabling the company to move...
, CDSCO.jpg)
.jpg)